{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:45:20Z","timestamp":1792079120240,"version":"4.4.0"},"reference-count":29,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Virtual reality\u2013based digital defocus vision training (DDVT) may offer a home-based strategy to slow myopia progression in children, but evidence is limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate efficacy and safety of a head-mounted virtual reality\u2013based DDVT system on myopia progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This randomized clinical trial was conducted among children aged 6 to 12 years with myopia enrolled in July 2024, with follow-up completed in September 2025. The trial was conducted at a single center in Guangzhou, China. Data were analyzed from September 2025 to October 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention<\/jats:title>\n                    <jats:p>Participants were randomized to DDVT plus single-vision spectacles (SVS) or SVS alone. Participants in the DDVT group used a head-mounted virtual reality device at home for 15 minutes per day under parental supervision after an initial in-hospital training session.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcome was the between-group difference in axial length (AL) change from baseline to 6 months. The secondary outcome was between-group difference in spherical equivalent refraction (SER) change.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 120 randomized participants, 57 of 60 participants in the DDVT group (95%) and 59 of 60 participants in the SVS group (98%) completed the study. At baseline, mean (SD) ages in the DDVT and SVS groups were 9.42 (1.52) years and 9.31 (1.13) years, respectively, and 53 of 116 participants (45.7%) were female. Mean (SD) AL and spherical equivalent in the DDVT and SVS groups were 24.35 (0.81) mm and 24.40 (0.81) mm and \u22121.91 (1.11) diopter (D) and \u22122.04 (1.06) D, respectively. Mean best-corrected visual acuity was \u22120.04 logMAR (Snellen equivalent, 20\/18) and \u22120.03 logMAR (20\/19), respectively. At 6 months, AL increased by 0.15 mm and 0.25 mm in the DDVT and SVS groups, respectively (difference\u2009=\u20090.11 mm; 95% CI, 0.07-0.15 mm;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001). SER changed by \u22120.23 D and \u22120.46 D (difference\u2009=\u2009\u22120.23 D; 95% CI, \u22120.35 to \u22120.11 D;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.003). Visual acuity change at 6 months was \u22120.02 logMAR (Snellen equivalent, 20\/18) and 0.01 logMAR (20\/20) in the DDVT and SVS groups, respectively (difference\u2009=\u20090.03 logMAR [Snellen equivalent, 20\/21]; 95% CI, 0.02-0.05 [20\/21-20\/22];\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001). No training-related adverse events were observed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this randomized clinical trial, the DDVT group had a small absolute reduction in AL and SER myopic progression compared with SVS alone over 6 months in 120 children with myopia aged 6 to 12 years. The clinical relevance of these differences over the short and long term cannot be determined from this trial but support additional studies to assess this intervention as a promising adjunctive approach for pediatric myopia control.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT07042022?cond=NCT07042022&amp;amp;amp;viewType=Card&amp;amp;amp;rank=1\">NCT07042022<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaophthalmol.2026.3490","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:30:35Z","timestamp":1787844635000},"page":"908","source":"Crossref","is-referenced-by-count":0,"title":["Digital Defocus Vision Training Using Virtual Reality for Myopia Control"],"prefix":"10.1001","volume":"144","author":[{"given":"Jing","family":"Zhong","sequence":"first","affiliation":[{"name":"Beijing Tongren Eye Center, Beijing Key Laboratory of Intelligent Diagnosis Technology and Equipment for Optic Nerve-Related Eye Diseases, National Engineering Research Center for Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[{"name":"Beijing Tongren Eye Center, Beijing Key Laboratory of Intelligent Diagnosis Technology and Equipment for Optic Nerve-Related Eye Diseases, National Engineering Research Center for Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianli","family":"Peng","sequence":"additional","affiliation":[{"name":"Beijing Tongren Eye Center, Beijing Key Laboratory of Intelligent Diagnosis Technology and Equipment for Optic Nerve-Related Eye Diseases, National Engineering Research Center for Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ma","sequence":"additional","affiliation":[{"name":"Beijing Tongren Eye Center, Beijing Key Laboratory of Intelligent Diagnosis Technology and Equipment for Optic Nerve-Related Eye Diseases, National Engineering Research Center for Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziting","family":"Huang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Guangdong Provincial Key Laboratory of Ophthalmology Visual Science, Sun Yat-sen University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Yang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Guangdong Provincial Key Laboratory of Ophthalmology Visual Science, Sun Yat-sen University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Ming","family":"Li","sequence":"additional","affiliation":[{"name":"Beijing Tongren Eye Center, Beijing Key Laboratory of Intelligent Diagnosis Technology and Equipment for Optic Nerve-Related Eye Diseases, National Engineering Research Center for Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Yuan","sequence":"additional","affiliation":[{"name":"Beijing Tongren Eye Center, Beijing Key Laboratory of Intelligent Diagnosis Technology and Equipment for Optic Nerve-Related Eye Diseases, National Engineering Research Center for Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"7543","key":"eoi260049r1","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/519276a","article-title":"The myopia boom.","volume":"519","author":"Dolgin","year":"2015","journal-title":"Nature"},{"issue":"8","key":"eoi260049r2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.28444","article-title":"The impact of the COVID-19 pandemic on myopia progression in children: a systematic review.","volume":"14","author":"Cyril Kurupp","year":"2022","journal-title":"Cureus"},{"key":"eoi260049r3","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.preteyeres.2017.09.004","article-title":"The epidemics of myopia: aetiology and prevention.","volume":"62","author":"Morgan","year":"2018","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"eoi260049r4","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1097\/IAE.0000000000001272","article-title":"Epidemic of pathologic myopia: what can laboratory studies and epidemiology tell us?","volume":"37","author":"Morgan","year":"2017","journal-title":"Retina"},{"issue":"9827","key":"eoi260049r5","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/S0140-6736(12)60272-4","article-title":"Myopia.","volume":"379","author":"Morgan","year":"2012","journal-title":"Lancet"},{"issue":"5","key":"eoi260049r6","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","article-title":"Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050.","volume":"123","author":"Holden","year":"2016","journal-title":"Ophthalmology"},{"issue":"3","key":"eoi260049r7","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/IAE.0000000000002590","article-title":"Prevalence and time trends of myopia in children and adolescents in China: a systemic review and meta-analysis.","volume":"40","author":"Dong","year":"2020","journal-title":"Retina"},{"issue":"11","key":"eoi260049r8","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1167\/iovs.05-0445","article-title":"Peripheral vision can influence eye growth and refractive development in infant monkeys.","volume":"46","author":"Smith","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"19","key":"eoi260049r9","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1016\/j.visres.2009.07.011","article-title":"Relative peripheral hyperopic defocus alters central refractive development in infant monkeys.","volume":"49","author":"Smith","year":"2009","journal-title":"Vision Res"},{"issue":"10","key":"eoi260049r10","doi-asserted-by":"publisher","first-page":"6765","DOI":"10.1167\/iovs.14-14524","article-title":"Axial eye growth and refractive error development can be modified by exposing the peripheral retina to relative myopic or hyperopic defocus.","volume":"55","author":"Benavente-P\u00e9rez","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"eoi260049r11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0042-6989(94)E0049-Q","article-title":"Moving the retina: choroidal modulation of refractive state.","volume":"35","author":"Wallman","year":"1995","journal-title":"Vision Res"},{"issue":"1","key":"eoi260049r12","doi-asserted-by":"publisher","first-page":"E23","DOI":"10.1097\/OPX.0b013e3181940669","article-title":"Biomechanics of the sclera in myopia: extracellular and cellular factors.","volume":"86","author":"McBrien","year":"2009","journal-title":"Optom Vis Sci"},{"issue":"1","key":"eoi260049r13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00417-022-05842-z","article-title":"Imposed positive defocus changes choroidal blood flow in young human subjects.","volume":"261","author":"Swiatczak","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"11","key":"eoi260049r14","doi-asserted-by":"publisher","first-page":"7077","DOI":"10.1167\/iovs.12-10565","article-title":"Retardation of Myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial.","volume":"53","author":"Cho","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"eoi260049r15","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.ophtha.2010.10.035","article-title":"Effect of dual-focus soft contact lens wear on axial myopia progression in children.","volume":"118","author":"Anstice","year":"2011","journal-title":"Ophthalmology"},{"issue":"5","key":"eoi260049r16","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00417-018-3906-z","article-title":"MiSight Assessment Study Spain (MASS). a 2-year randomized clinical trial.","volume":"256","author":"Ruiz-Pomeda","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"7","key":"eoi260049r17","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/aos.14773","article-title":"The influence of the choroid on the onset and development of myopia: from perspectives of choroidal thickness and blood flow.","volume":"99","author":"Liu","year":"2021","journal-title":"Acta Ophthalmol"},{"issue":"14","key":"eoi260049r18","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1017\/S003329171700040X","article-title":"Virtual reality in the assessment, understanding, and treatment of mental health disorders.","volume":"47","author":"Freeman","year":"2017","journal-title":"Psychol Med"},{"key":"eoi260049r19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mehy.2018.09.021","article-title":"Virtual reality: a possible approach to myopia prevention and control?","volume":"121","author":"Zhao","year":"2018","journal-title":"Med Hypotheses"},{"issue":"1","key":"eoi260049r20","doi-asserted-by":"publisher","first-page":"16172","DOI":"10.1038\/s41598-017-16320-6","article-title":"Ocular effects of virtual reality headset wear in young adults.","volume":"7","author":"Turnbull","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"eoi260049r21","doi-asserted-by":"publisher","first-page":"15382","DOI":"10.1038\/s41598-021-94680-w","article-title":"Effects of prolonged use of virtual reality smartphone-based head-mounted display on visual parameters: a randomised controlled trial.","volume":"11","author":"Yoon","year":"2021","journal-title":"Sci Rep"},{"issue":"11","key":"eoi260049r22","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1097\/OPX.0000000000000040","article-title":"Spherical aberration and the sign of defocus.","volume":"90","author":"Thibos","year":"2013","journal-title":"Optom Vis Sci"},{"issue":"3","key":"eoi260049r23","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.optom.2020.02.004","article-title":"The effect of gaming on accommodative and vergence facilities after exposure to virtual reality head-mounted display.","volume":"13","author":"Munsamy","year":"2020","journal-title":"J Optom"},{"issue":"22","key":"eoi260049r24","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1001\/jama.2025.4347","article-title":"CONSORT 2025 statement: updated guideline for reporting randomized trials.","volume":"333","author":"Hopewell","year":"2025","journal-title":"JAMA"},{"issue":"1697","key":"eoi260049r25","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2015.0264","article-title":"Recovering stereo vision by squashing virtual bugs in a virtual reality environment.","volume":"371","author":"Vedamurthy","year":"2016","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"1","key":"eoi260049r26","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12886-017-0501-8","article-title":"Amblyopia treatment of adults with dichoptic training using the virtual reality oculus rift head mounted display: preliminary results.","volume":"17","author":"\u017diak","year":"2017","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"eoi260049r27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/ICL.0000000000000219","article-title":"The safety of orthokeratology\u2013a systematic review.","volume":"42","author":"Liu","year":"2016","journal-title":"Eye Contact Lens"},{"issue":"6","key":"eoi260049r28","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1001\/jamaophthalmol.2017.1091","article-title":"Efficacy and adverse effects of atropine in childhood myopia: a meta-analysis.","volume":"135","author":"Gong","year":"2017","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"eoi260049r29","doi-asserted-by":"publisher","first-page":"5475","DOI":"10.1038\/s41598-023-32700-7","article-title":"Long-term myopia control effect and safety in children wearing DIMS spectacle lenses for 6 years.","volume":"13","author":"Lam","year":"2023","journal-title":"Sci Rep"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2853325\/jamaophthalmology_zhong_2026_oi_260049_1791404752.61639.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:00:41Z","timestamp":1792076441000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2853325"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2026.3490","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,1]]}}}